Therapeutics Development companies

A leading European Venture Capital firm investing in early- and growth-stage Life Science companies.

Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.

AGP is a fund management company focused on healthcare investments from venture to growth-stage.

A £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.